STRO Return on Tangible Equity | SUTRO BIOPHARMA, INC.

SUTRO BIOPHARMA, INC. (STRO) Return on Tangible Equity

2026-06-30: Return Tang Equity 174.84%.
2026-03-31: Return Tang Equity 229.64%.
2025-12-31: Return Tang Equity 144.27%.
2025-09-30: Return Tang Equity 248.39%.

Complete source-backed return tang equity history.

Available history: 2016-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	174.84%
2026-03-31	229.64%
2025-12-31	144.27%
2025-09-30	248.39%
2025-06-30	649.92%
2025-03-31	950.04%
2024-12-31	-509.99%
2024-09-30	-111.45%
2024-06-30	-81.78%
2024-03-31	-117.27%
2023-12-31	-71.36%
2023-09-30	-153.38%
2023-06-30	-92.21%
2023-03-31	-70.19%
2022-12-31	-54.92%
2022-09-30	-53.43%
2022-06-30	-64.17%
2022-03-31	-51.86%
2021-12-31	-41.79%
2021-09-30	-44.77%
2021-06-30	-25.66%
2021-03-31	-13.96%
2020-12-31	-9.68%
2020-09-30	-20.82%
2020-06-30	-39.12%
2020-03-31	-151.73%
2019-12-31	-121.90%
2019-09-30	-38.62%
2019-06-30	-33.27%
2019-03-31	-28.70%
2018-12-31	-26.85%
2018-09-30	34.76%
2018-06-30	30.56%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	144.27%
2024-12-31	-509.99%
2023-12-31	-71.36%
2022-12-31	-54.92%
2021-12-31	-41.79%
2020-12-31	-9.68%
2019-12-31	-121.90%
2018-12-31	-26.85%
2017-12-31	18.06%
2016-12-31	-1.87%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Invivyd, Inc. (IVVD)	United States	$0.270B	-2.42
PALISADE BIO, INC. (PALI)	United States	$0.275B	-11.41
Lexeo Therapeutics, Inc. (LXEO)	United States	$0.278B	-4.19
Lineage Cell Therapeutics, Inc. (LCTX)	United States	$0.241B	-10.35
FATE THERAPEUTICS INC (FATE)	United States	$0.280B	-2.51
Liminatus Pharma, Inc. (LIMN)	United States	$0.282B
Aligos Therapeutics, Inc. (ALGS)	United States	$0.238B	-0.47
Inhibikase Therapeutics, Inc. (IKT)	United States	$0.296B	-4.44
X4 Pharmaceuticals, Inc (XFOR)	United States	$0.297B	-4.99
Protalix BioTherapeutics, Inc. (PLX)		$0.221B	9.87